Company Filing History:
Years Active: 2015-2018
Title: Innovations of Amit Nargotra
Introduction
Amit Nargotra is a notable inventor based in Jammu, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various medical conditions. With a total of 4 patents to his name, Nargotra's work focuses on innovative solutions that address critical health issues.
Latest Patents
One of Nargotra's latest patents is titled "Pyrazolopyrimidinones for the treatment of impotence and process for the preparation thereof." This invention relates to Pyrazolopyrimidinone compounds that act as PDE5 inhibitors, demonstrating improved IC values, good in vivo efficacy, and a favorable pharmacokinetic profile. The compounds have been designed, synthesized, and screened for their PDE5 inhibitory activity, showing nanomolar potency and potential for treating male erectile dysfunction.
Another significant patent is "1,3,5-triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof." This invention describes heterocyclic compounds that inhibit phosphoinositide 3-kinase (PI3K), offering promising applications as anticancer agents. The method of preparation for these compounds is also detailed in the patent.
Career Highlights
Amit Nargotra is affiliated with the Council of Scientific & Industrial Research, where he continues to engage in groundbreaking research and development. His work has garnered attention for its potential impact on healthcare and treatment methodologies.
Collaborations
Nargotra has collaborated with notable colleagues, including Ram Asrey Vishwakarma and Sanghapal Damodhar Sawant. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Amit Nargotra's innovative contributions to the pharmaceutical field highlight his commitment to addressing significant health challenges. His patents reflect a dedication to improving treatment options for conditions such as erectile dysfunction and cancer.